Latest Market Investments News

Page 3 of 9
Vita Life Sciences has reported a strong FY2025 with record revenue of $93.3 million and net profit after tax rising 18.8%, while declaring a 14.0 cents per share dividend.
Ada Torres
Ada Torres
16 Feb 2026
Temple & Webster has reported a robust 20% increase in half-year revenue to $376 million, expanding its market share and launching successfully into New Zealand. EBITDA remains within guidance despite new market investments.
Logan Eniac
Logan Eniac
12 Feb 2026
WAM Active Limited has launched a $51.4 million pro-rata entitlement offer at a 7.8% discount to the recent share price, alongside a $19.3 million institutional placement to meet strong investor demand. The capital raising aims to bolster the company’s proven Australian equity investment strategy while offering shareholders fully franked dividends on new shares.
Claire Turing
Claire Turing
6 Feb 2026
Mayfield Childcare Limited reported stable revenue and improved profitability in Q4 FY25, outpacing peers in occupancy growth while rejecting a takeover offer from Embark Early Education.
Victor Sage
Victor Sage
30 Jan 2026
IGO Limited reports a robust quarter with improved safety, higher spodumene production and prices at Greenbushes, successful commissioning of CGP3, and solid performance at Nova. Despite challenges at Kwinana refinery, the group’s underlying EBITDA and cash flow strengthened.
Maxwell Dee
Maxwell Dee
29 Jan 2026
Magellan Investment Partners has launched the Magellan Global Equities Fund (Currency Hedged), an actively managed ETF listed on the ASX under ticker MHG, targeting a 9% annual return with integrated ESG considerations.
Claire Turing
Claire Turing
17 Dec 2025
Collins Foods Limited reported solid half-year growth with revenue up 6.6% and net profit rising 12.7%, driven by strong performance in its KFC operations across Australia and Europe. The company declared a fully franked interim dividend of 13 cents per share, while navigating increased provisions linked to wage compliance and ongoing class action litigation.
Victor Sage
Victor Sage
2 Dec 2025
Aroa Biosurgery reported a 14% rise in product sales to NZ$44.6 million for the half-year ended September 2025, driven by strong growth in its Myriad portfolio. The company also posted a normalised EBITDA profit and reaffirmed its FY26 revenue and profit guidance.
Ada Torres
Ada Torres
25 Nov 2025
Bubs Australia Limited reported a solid FY25 with $102.5 million revenue and outlined ambitious FY26 guidance targeting up to $125 million, driven by overseas markets and strategic investments.
Victor Sage
Victor Sage
20 Nov 2025
Airtasker Limited has announced a $10 million equity capital raise to accelerate marketing efforts in the UK and US, following a strong first quarter with group revenue up 20.5% year-on-year. Strategic partnerships, including a cornerstone investment from iHeartMedia, underpin its international growth ambitions.
Sophie Babbage
Sophie Babbage
17 Nov 2025
FSI’s FY2025 portfolio posted a modest 5.0% return, trailing the ASX All Ordinaries Index, while maintaining dividend growth and planning a strategic move into pre-IPO investments.
Claire Turing
Claire Turing
6 Nov 2025
InFocus Group Holdings has launched two new strategic units targeting digital assets and iGaming, backed by a significant loan and guided by a newly formed advisory board featuring industry veterans.
Sophie Babbage
Sophie Babbage
31 Oct 2025

Browse the archive

Full archive